Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial

Published:2014-10 Issue:10 Volume:14 Page:939-946
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Satti Iman,Meyer Joel,Harris Stephanie A,Thomas Zita-Rose Manjaly,Griffiths Kristin,Antrobus Richard D,Rowland Rosalind,Ramon Raquel Lopez,Smith Mary,Sheehan Sharon,Bettinson Henry,McShane Helen

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness;Trunz;Lancet,2006

2. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature;Colditz;JAMA,1994

3. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans;McShane;Nat Med,2004

4. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis;Rodrigues;Int J Epidemiol,1993

5. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis;Santosuosso;Infect Immun,2006

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial;The Lancet Infectious Diseases;2024-08

2. A new tool for accelerating tuberculosis vaccine development;The Lancet Infectious Diseases;2024-08

3. Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route;Journal of Infection;2024-08

4. Inhaled aerosol viral-vectored vaccines against tuberculosis;Current Opinion in Virology;2024-06

5. Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal;Heliyon;2024-02